Cargando…

In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid

BACKGROUND: hyaluronic acid (HA), a non-sulphated glycosaminoglycan, is present in synovial fluid, vitreous humour serum and many connective tissues. Pharmaceutical preparations of HA are used in clinical practice for wound healing, joint pain, kerato-conjunctivitis, asthma, mouth care, oesophageal-...

Descripción completa

Detalles Bibliográficos
Autores principales: Cermelli, Claudio, Cuoghi, Alessandro, Scuri, Monica, Bettua, Clotilde, Neglia, Rachele G, Ardizzoni, Andrea, Blasi, Elisabetta, Iannitti, Tommaso, Palmieri, Beniamino
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073889/
https://www.ncbi.nlm.nih.gov/pubmed/21439070
http://dx.doi.org/10.1186/1743-422X-8-141
_version_ 1782201653938618368
author Cermelli, Claudio
Cuoghi, Alessandro
Scuri, Monica
Bettua, Clotilde
Neglia, Rachele G
Ardizzoni, Andrea
Blasi, Elisabetta
Iannitti, Tommaso
Palmieri, Beniamino
author_facet Cermelli, Claudio
Cuoghi, Alessandro
Scuri, Monica
Bettua, Clotilde
Neglia, Rachele G
Ardizzoni, Andrea
Blasi, Elisabetta
Iannitti, Tommaso
Palmieri, Beniamino
author_sort Cermelli, Claudio
collection PubMed
description BACKGROUND: hyaluronic acid (HA), a non-sulphated glycosaminoglycan, is present in synovial fluid, vitreous humour serum and many connective tissues. Pharmaceutical preparations of HA are used in clinical practice for wound healing, joint pain, kerato-conjunctivitis, asthma, mouth care, oesophageal-reflux, and gastritis. Moreover, it is used as a filler to counteract ageing and facial lipoatrophy. Our study aims at investigating the in vitro antiviral activity of a high molecular weight HA. METHODS: the MTT test was used to rule out the potential toxic effects of HA on the different cell lines used in the antiviral assays. The antiviral activity of HA against Coxsackievirus B5, Herpes Simplex Virus-1, Mumps Virus, Adenovirus-5, Influenza Virus A/H1N1, Human Herpesvirus-6, Porcine Parvovirus, Porcine Reproductive and Respiratory Syndrome Virus was assessed by virus yield assays. RESULTS: the most effective inhibition was observed against Coxsackievirus B5, with 3Log reduction of the virus yield at 4 mg/ml, and a reduction of 3.5Log and 2Log, at 2 mg/ml and 1 mg/ml, respectively: the selectivity index was 16. Mumps virus was highly inhibited too showing a reduction of 1.7Log at 1 mg/ml and 1Log at 4 mg/ml and 2 mg/ml (selectivity index = 12). The selectivity index for Influenza Virus was 12 with the highest inhibition (1Log) observed at 4 mg/ml. Herpes Simplex Virus-1 and Porcine Parvovirus were mildly inhibited, whereas no antiviral activity was observed with respect to Adenovirus-5, Human Herpesvirus-6, Porcine Reproductive and Respiratory Syndrome Virus. No HA virucidal activity was ever observed against any of the viruses tested. Kinetic experiments showed that both Coxsackievirus B5 and Herpes simplex virus-1 replication were consistently inhibited, not influenced by the time of HA addition, during the virus replication cycle. CONCLUSIONS: the spectrum of the antiviral activity exhibited by HA against both RNA and DNA viruses, known to have different structures (with or without envelope) and replication strategies, suggests a non specific mechanism of action, probably involving cell membrane-virus interaction steps. The results of the kinetic experiments support this hypothesis.
format Text
id pubmed-3073889
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-30738892011-04-12 In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid Cermelli, Claudio Cuoghi, Alessandro Scuri, Monica Bettua, Clotilde Neglia, Rachele G Ardizzoni, Andrea Blasi, Elisabetta Iannitti, Tommaso Palmieri, Beniamino Virol J Research BACKGROUND: hyaluronic acid (HA), a non-sulphated glycosaminoglycan, is present in synovial fluid, vitreous humour serum and many connective tissues. Pharmaceutical preparations of HA are used in clinical practice for wound healing, joint pain, kerato-conjunctivitis, asthma, mouth care, oesophageal-reflux, and gastritis. Moreover, it is used as a filler to counteract ageing and facial lipoatrophy. Our study aims at investigating the in vitro antiviral activity of a high molecular weight HA. METHODS: the MTT test was used to rule out the potential toxic effects of HA on the different cell lines used in the antiviral assays. The antiviral activity of HA against Coxsackievirus B5, Herpes Simplex Virus-1, Mumps Virus, Adenovirus-5, Influenza Virus A/H1N1, Human Herpesvirus-6, Porcine Parvovirus, Porcine Reproductive and Respiratory Syndrome Virus was assessed by virus yield assays. RESULTS: the most effective inhibition was observed against Coxsackievirus B5, with 3Log reduction of the virus yield at 4 mg/ml, and a reduction of 3.5Log and 2Log, at 2 mg/ml and 1 mg/ml, respectively: the selectivity index was 16. Mumps virus was highly inhibited too showing a reduction of 1.7Log at 1 mg/ml and 1Log at 4 mg/ml and 2 mg/ml (selectivity index = 12). The selectivity index for Influenza Virus was 12 with the highest inhibition (1Log) observed at 4 mg/ml. Herpes Simplex Virus-1 and Porcine Parvovirus were mildly inhibited, whereas no antiviral activity was observed with respect to Adenovirus-5, Human Herpesvirus-6, Porcine Reproductive and Respiratory Syndrome Virus. No HA virucidal activity was ever observed against any of the viruses tested. Kinetic experiments showed that both Coxsackievirus B5 and Herpes simplex virus-1 replication were consistently inhibited, not influenced by the time of HA addition, during the virus replication cycle. CONCLUSIONS: the spectrum of the antiviral activity exhibited by HA against both RNA and DNA viruses, known to have different structures (with or without envelope) and replication strategies, suggests a non specific mechanism of action, probably involving cell membrane-virus interaction steps. The results of the kinetic experiments support this hypothesis. BioMed Central 2011-03-25 /pmc/articles/PMC3073889/ /pubmed/21439070 http://dx.doi.org/10.1186/1743-422X-8-141 Text en Copyright ©2011 Cermelli et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Cermelli, Claudio
Cuoghi, Alessandro
Scuri, Monica
Bettua, Clotilde
Neglia, Rachele G
Ardizzoni, Andrea
Blasi, Elisabetta
Iannitti, Tommaso
Palmieri, Beniamino
In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
title In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
title_full In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
title_fullStr In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
title_full_unstemmed In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
title_short In vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
title_sort in vitro evaluation of antiviral and virucidal activity of a high molecular weight hyaluronic acid
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3073889/
https://www.ncbi.nlm.nih.gov/pubmed/21439070
http://dx.doi.org/10.1186/1743-422X-8-141
work_keys_str_mv AT cermelliclaudio invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT cuoghialessandro invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT scurimonica invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT bettuaclotilde invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT negliaracheleg invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT ardizzoniandrea invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT blasielisabetta invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT iannittitommaso invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid
AT palmieribeniamino invitroevaluationofantiviralandvirucidalactivityofahighmolecularweighthyaluronicacid